nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—hepatic artery—colon cancer	0.145	0.199	CbGeAlD
Cysteamine—SST—portal vein—colon cancer	0.126	0.173	CbGeAlD
Cysteamine—SST—myenteric nerve plexus—colon cancer	0.113	0.154	CbGeAlD
Cysteamine—MPO—superior mesenteric artery—colon cancer	0.111	0.153	CbGeAlD
Cysteamine—SST—vein—colon cancer	0.0726	0.0994	CbGeAlD
Cysteamine—SST—blood vessel—colon cancer	0.023	0.0316	CbGeAlD
Cysteamine—SST—gall bladder—colon cancer	0.0217	0.0297	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Fluorouracil—colon cancer	0.0175	0.0648	CcSEcCtD
Cysteamine—Mass—Capecitabine—colon cancer	0.0162	0.0598	CcSEcCtD
Cysteamine—SST—embryo—colon cancer	0.0137	0.0188	CbGeAlD
Cysteamine—Gastrointestinal ulcer—Methotrexate—colon cancer	0.0113	0.0417	CcSEcCtD
Cysteamine—SST—epithelium—colon cancer	0.0112	0.0154	CbGeAlD
Cysteamine—SST—smooth muscle tissue—colon cancer	0.0108	0.0148	CbGeAlD
Cysteamine—SST—renal system—colon cancer	0.0104	0.0142	CbGeAlD
Cysteamine—MPO—endothelium—colon cancer	0.0101	0.0138	CbGeAlD
Cysteamine—MPO—blood vessel—colon cancer	0.00927	0.0127	CbGeAlD
Cysteamine—Gastrointestinal ulcer haemorrhage—Methotrexate—colon cancer	0.0091	0.0337	CcSEcCtD
Cysteamine—SST—lymphoid tissue—colon cancer	0.00863	0.0118	CbGeAlD
Cysteamine—SST—digestive system—colon cancer	0.00853	0.0117	CbGeAlD
Cysteamine—Duodenitis—Capecitabine—colon cancer	0.00798	0.0295	CcSEcCtD
Cysteamine—SST—liver—colon cancer	0.00635	0.0087	CbGeAlD
Cysteamine—Encephalopathy—Fluorouracil—colon cancer	0.00523	0.0193	CcSEcCtD
Cysteamine—SST—lymph node—colon cancer	0.00487	0.00667	CbGeAlD
Cysteamine—MPO—epithelium—colon cancer	0.00451	0.00619	CbGeAlD
Cysteamine—MPO—renal system—colon cancer	0.00419	0.00574	CbGeAlD
Cysteamine—Encephalopathy—Capecitabine—colon cancer	0.00365	0.0135	CcSEcCtD
Cysteamine—Appetite absent—Methotrexate—colon cancer	0.00351	0.013	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Irinotecan—colon cancer	0.0035	0.013	CcSEcCtD
Cysteamine—MPO—lymphoid tissue—colon cancer	0.00348	0.00476	CbGeAlD
Cysteamine—MPO—digestive system—colon cancer	0.00343	0.00471	CbGeAlD
Cysteamine—MPO—bone marrow—colon cancer	0.00317	0.00434	CbGeAlD
Cysteamine—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00292	0.0108	CcSEcCtD
Cysteamine—Encephalopathy—Methotrexate—colon cancer	0.00272	0.0101	CcSEcCtD
Cysteamine—Pain in extremity—Vincristine—colon cancer	0.00261	0.00966	CcSEcCtD
Cysteamine—MPO—liver—colon cancer	0.00256	0.00351	CbGeAlD
Cysteamine—Lethargy—Fluorouracil—colon cancer	0.00248	0.0092	CcSEcCtD
Cysteamine—Ataxia—Vincristine—colon cancer	0.00245	0.00908	CcSEcCtD
Cysteamine—Dehydration—Vincristine—colon cancer	0.00243	0.00898	CcSEcCtD
Cysteamine—Dehydration—Irinotecan—colon cancer	0.00236	0.00875	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Capecitabine—colon cancer	0.00234	0.00868	CcSEcCtD
Cysteamine—Ataxia—Fluorouracil—colon cancer	0.00229	0.00847	CcSEcCtD
Cysteamine—Mental disability—Capecitabine—colon cancer	0.00203	0.00753	CcSEcCtD
Cysteamine—MPO—lymph node—colon cancer	0.00196	0.00269	CbGeAlD
Cysteamine—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00196	0.00724	CcSEcCtD
Cysteamine—Hepatic function abnormal—Capecitabine—colon cancer	0.00195	0.00721	CcSEcCtD
Cysteamine—Bone disorder—Methotrexate—colon cancer	0.00193	0.00715	CcSEcCtD
Cysteamine—Renal failure—Irinotecan—colon cancer	0.00193	0.00713	CcSEcCtD
Cysteamine—Gastroenteritis—Capecitabine—colon cancer	0.00192	0.0071	CcSEcCtD
Cysteamine—Eye pain—Capecitabine—colon cancer	0.00188	0.00698	CcSEcCtD
Cysteamine—Hallucination—Vincristine—colon cancer	0.0018	0.00665	CcSEcCtD
Cysteamine—Urinary tract disorder—Vincristine—colon cancer	0.00178	0.0066	CcSEcCtD
Cysteamine—Connective tissue disorder—Vincristine—colon cancer	0.00177	0.00657	CcSEcCtD
Cysteamine—Urethral disorder—Vincristine—colon cancer	0.00177	0.00655	CcSEcCtD
Cysteamine—Lethargy—Capecitabine—colon cancer	0.00174	0.00643	CcSEcCtD
Cysteamine—Connective tissue disorder—Irinotecan—colon cancer	0.00173	0.0064	CcSEcCtD
Cysteamine—Pain in extremity—Capecitabine—colon cancer	0.0017	0.0063	CcSEcCtD
Cysteamine—Mood swings—Capecitabine—colon cancer	0.00161	0.00597	CcSEcCtD
Cysteamine—Ataxia—Capecitabine—colon cancer	0.0016	0.00592	CcSEcCtD
Cysteamine—Immune system disorder—Irinotecan—colon cancer	0.00159	0.00588	CcSEcCtD
Cysteamine—Dehydration—Capecitabine—colon cancer	0.00158	0.00586	CcSEcCtD
Cysteamine—Mental disorder—Vincristine—colon cancer	0.00158	0.00586	CcSEcCtD
Cysteamine—Liver function test abnormal—Capecitabine—colon cancer	0.00157	0.00581	CcSEcCtD
Cysteamine—Erythema—Fluorouracil—colon cancer	0.00147	0.00543	CcSEcCtD
Cysteamine—Anaemia—Vincristine—colon cancer	0.00145	0.00538	CcSEcCtD
Cysteamine—Agitation—Vincristine—colon cancer	0.00144	0.00535	CcSEcCtD
Cysteamine—Anaemia—Irinotecan—colon cancer	0.00142	0.00524	CcSEcCtD
Cysteamine—Leukopenia—Vincristine—colon cancer	0.00141	0.00521	CcSEcCtD
Cysteamine—Leukopenia—Irinotecan—colon cancer	0.00137	0.00507	CcSEcCtD
Cysteamine—Convulsion—Vincristine—colon cancer	0.00136	0.00504	CcSEcCtD
Cysteamine—Hypertension—Vincristine—colon cancer	0.00136	0.00502	CcSEcCtD
Cysteamine—Anaemia—Fluorouracil—colon cancer	0.00136	0.00502	CcSEcCtD
Cysteamine—Hypertension—Irinotecan—colon cancer	0.00132	0.00489	CcSEcCtD
Cysteamine—Leukopenia—Fluorouracil—colon cancer	0.00131	0.00486	CcSEcCtD
Cysteamine—Lethargy—Methotrexate—colon cancer	0.00129	0.00478	CcSEcCtD
Cysteamine—Renal failure—Capecitabine—colon cancer	0.00129	0.00477	CcSEcCtD
Cysteamine—Discomfort—Irinotecan—colon cancer	0.00129	0.00477	CcSEcCtD
Cysteamine—Anaphylactic shock—Vincristine—colon cancer	0.00128	0.00475	CcSEcCtD
Cysteamine—Convulsion—Fluorouracil—colon cancer	0.00127	0.0047	CcSEcCtD
Cysteamine—Confusional state—Irinotecan—colon cancer	0.00126	0.00466	CcSEcCtD
Cysteamine—Nervous system disorder—Vincristine—colon cancer	0.00126	0.00466	CcSEcCtD
Cysteamine—Anaphylactic shock—Irinotecan—colon cancer	0.00125	0.00462	CcSEcCtD
Cysteamine—Discomfort—Fluorouracil—colon cancer	0.00123	0.00456	CcSEcCtD
Cysteamine—Nervous system disorder—Irinotecan—colon cancer	0.00123	0.00454	CcSEcCtD
Cysteamine—Anorexia—Vincristine—colon cancer	0.00122	0.00453	CcSEcCtD
Cysteamine—Confusional state—Fluorouracil—colon cancer	0.00121	0.00447	CcSEcCtD
Cysteamine—Mood swings—Methotrexate—colon cancer	0.0012	0.00444	CcSEcCtD
Cysteamine—Anaphylactic shock—Fluorouracil—colon cancer	0.0012	0.00443	CcSEcCtD
Cysteamine—Anorexia—Irinotecan—colon cancer	0.00119	0.00441	CcSEcCtD
Cysteamine—Ataxia—Methotrexate—colon cancer	0.00119	0.00441	CcSEcCtD
Cysteamine—Nervous system disorder—Fluorouracil—colon cancer	0.00117	0.00434	CcSEcCtD
Cysteamine—Liver function test abnormal—Methotrexate—colon cancer	0.00117	0.00433	CcSEcCtD
Cysteamine—Urinary tract disorder—Capecitabine—colon cancer	0.00116	0.0043	CcSEcCtD
Cysteamine—Connective tissue disorder—Capecitabine—colon cancer	0.00116	0.00428	CcSEcCtD
Cysteamine—Urethral disorder—Capecitabine—colon cancer	0.00115	0.00427	CcSEcCtD
Cysteamine—Anorexia—Fluorouracil—colon cancer	0.00114	0.00422	CcSEcCtD
Cysteamine—Decreased appetite—Vincristine—colon cancer	0.00112	0.00413	CcSEcCtD
Cysteamine—Somnolence—Irinotecan—colon cancer	0.00111	0.00411	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vincristine—colon cancer	0.00111	0.0041	CcSEcCtD
Cysteamine—Fatigue—Vincristine—colon cancer	0.00111	0.00409	CcSEcCtD
Cysteamine—Dyspepsia—Irinotecan—colon cancer	0.0011	0.00407	CcSEcCtD
Cysteamine—Constipation—Vincristine—colon cancer	0.0011	0.00406	CcSEcCtD
Cysteamine—Decreased appetite—Irinotecan—colon cancer	0.00109	0.00402	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00108	0.00399	CcSEcCtD
Cysteamine—Fatigue—Irinotecan—colon cancer	0.00108	0.00399	CcSEcCtD
Cysteamine—Constipation—Irinotecan—colon cancer	0.00107	0.00395	CcSEcCtD
Cysteamine—Somnolence—Fluorouracil—colon cancer	0.00106	0.00394	CcSEcCtD
Cysteamine—Immune system disorder—Capecitabine—colon cancer	0.00106	0.00393	CcSEcCtD
Cysteamine—Dyspepsia—Fluorouracil—colon cancer	0.00105	0.0039	CcSEcCtD
Cysteamine—Gastrointestinal pain—Vincristine—colon cancer	0.00105	0.00388	CcSEcCtD
Cysteamine—Decreased appetite—Fluorouracil—colon cancer	0.00104	0.00385	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00103	0.00382	CcSEcCtD
Cysteamine—Mental disorder—Capecitabine—colon cancer	0.00103	0.00382	CcSEcCtD
Cysteamine—Feeling abnormal—Irinotecan—colon cancer	0.00103	0.00381	CcSEcCtD
Cysteamine—Erythema—Capecitabine—colon cancer	0.00102	0.00379	CcSEcCtD
Cysteamine—Malnutrition—Capecitabine—colon cancer	0.00102	0.00379	CcSEcCtD
Cysteamine—Gastrointestinal pain—Irinotecan—colon cancer	0.00102	0.00378	CcSEcCtD
Cysteamine—Body temperature increased—Vincristine—colon cancer	0.00101	0.00375	CcSEcCtD
Cysteamine—Abdominal pain—Vincristine—colon cancer	0.00101	0.00375	CcSEcCtD
Cysteamine—Abdominal pain—Irinotecan—colon cancer	0.000988	0.00366	CcSEcCtD
Cysteamine—Body temperature increased—Irinotecan—colon cancer	0.000988	0.00366	CcSEcCtD
Cysteamine—Feeling abnormal—Fluorouracil—colon cancer	0.000986	0.00365	CcSEcCtD
Cysteamine—Tremor—Capecitabine—colon cancer	0.00096	0.00355	CcSEcCtD
Cysteamine—Renal failure—Methotrexate—colon cancer	0.00096	0.00355	CcSEcCtD
Cysteamine—Urticaria—Fluorouracil—colon cancer	0.000951	0.00352	CcSEcCtD
Cysteamine—Anaemia—Capecitabine—colon cancer	0.000947	0.00351	CcSEcCtD
Cysteamine—Body temperature increased—Fluorouracil—colon cancer	0.000946	0.0035	CcSEcCtD
Cysteamine—Hypersensitivity—Vincristine—colon cancer	0.000945	0.0035	CcSEcCtD
Cysteamine—Hypersensitivity—Irinotecan—colon cancer	0.000921	0.00341	CcSEcCtD
Cysteamine—Asthenia—Vincristine—colon cancer	0.000921	0.00341	CcSEcCtD
Cysteamine—Leukopenia—Capecitabine—colon cancer	0.000917	0.00339	CcSEcCtD
Cysteamine—Asthenia—Irinotecan—colon cancer	0.000897	0.00332	CcSEcCtD
Cysteamine—Hypertension—Capecitabine—colon cancer	0.000885	0.00327	CcSEcCtD
Cysteamine—Hypersensitivity—Fluorouracil—colon cancer	0.000882	0.00326	CcSEcCtD
Cysteamine—Diarrhoea—Vincristine—colon cancer	0.000878	0.00325	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000866	0.00321	CcSEcCtD
Cysteamine—Urinary tract disorder—Methotrexate—colon cancer	0.000865	0.0032	CcSEcCtD
Cysteamine—Discomfort—Capecitabine—colon cancer	0.000862	0.00319	CcSEcCtD
Cysteamine—Urethral disorder—Methotrexate—colon cancer	0.000859	0.00318	CcSEcCtD
Cysteamine—Diarrhoea—Irinotecan—colon cancer	0.000855	0.00316	CcSEcCtD
Cysteamine—Dizziness—Vincristine—colon cancer	0.000848	0.00314	CcSEcCtD
Cysteamine—Confusional state—Capecitabine—colon cancer	0.000843	0.00312	CcSEcCtD
Cysteamine—Dizziness—Irinotecan—colon cancer	0.000826	0.00306	CcSEcCtD
Cysteamine—Nervous system disorder—Capecitabine—colon cancer	0.00082	0.00304	CcSEcCtD
Cysteamine—Diarrhoea—Fluorouracil—colon cancer	0.000819	0.00303	CcSEcCtD
Cysteamine—Vomiting—Vincristine—colon cancer	0.000816	0.00302	CcSEcCtD
Cysteamine—Skin disorder—Capecitabine—colon cancer	0.000812	0.00301	CcSEcCtD
Cysteamine—Rash—Vincristine—colon cancer	0.000809	0.00299	CcSEcCtD
Cysteamine—Dermatitis—Vincristine—colon cancer	0.000808	0.00299	CcSEcCtD
Cysteamine—Headache—Vincristine—colon cancer	0.000804	0.00297	CcSEcCtD
Cysteamine—Anorexia—Capecitabine—colon cancer	0.000797	0.00295	CcSEcCtD
Cysteamine—Vomiting—Irinotecan—colon cancer	0.000794	0.00294	CcSEcCtD
Cysteamine—Immune system disorder—Methotrexate—colon cancer	0.000792	0.00293	CcSEcCtD
Cysteamine—Dizziness—Fluorouracil—colon cancer	0.000791	0.00293	CcSEcCtD
Cysteamine—Rash—Irinotecan—colon cancer	0.000788	0.00292	CcSEcCtD
Cysteamine—Dermatitis—Irinotecan—colon cancer	0.000787	0.00291	CcSEcCtD
Cysteamine—Headache—Irinotecan—colon cancer	0.000783	0.0029	CcSEcCtD
Cysteamine—Mental disorder—Methotrexate—colon cancer	0.000768	0.00284	CcSEcCtD
Cysteamine—Malnutrition—Methotrexate—colon cancer	0.000763	0.00282	CcSEcCtD
Cysteamine—Erythema—Methotrexate—colon cancer	0.000763	0.00282	CcSEcCtD
Cysteamine—Nausea—Vincristine—colon cancer	0.000762	0.00282	CcSEcCtD
Cysteamine—Vomiting—Fluorouracil—colon cancer	0.000761	0.00282	CcSEcCtD
Cysteamine—Rash—Fluorouracil—colon cancer	0.000755	0.00279	CcSEcCtD
Cysteamine—Dermatitis—Fluorouracil—colon cancer	0.000754	0.00279	CcSEcCtD
Cysteamine—Headache—Fluorouracil—colon cancer	0.00075	0.00277	CcSEcCtD
Cysteamine—Nausea—Irinotecan—colon cancer	0.000742	0.00275	CcSEcCtD
Cysteamine—Dyspepsia—Capecitabine—colon cancer	0.000736	0.00272	CcSEcCtD
Cysteamine—Decreased appetite—Capecitabine—colon cancer	0.000727	0.00269	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000722	0.00267	CcSEcCtD
Cysteamine—Fatigue—Capecitabine—colon cancer	0.000721	0.00267	CcSEcCtD
Cysteamine—Constipation—Capecitabine—colon cancer	0.000715	0.00265	CcSEcCtD
Cysteamine—Nausea—Fluorouracil—colon cancer	0.000711	0.00263	CcSEcCtD
Cysteamine—Anaemia—Methotrexate—colon cancer	0.000705	0.00261	CcSEcCtD
Cysteamine—Feeling abnormal—Capecitabine—colon cancer	0.000689	0.00255	CcSEcCtD
Cysteamine—Gastrointestinal pain—Capecitabine—colon cancer	0.000684	0.00253	CcSEcCtD
Cysteamine—Leukopenia—Methotrexate—colon cancer	0.000683	0.00253	CcSEcCtD
Cysteamine—Urticaria—Capecitabine—colon cancer	0.000664	0.00246	CcSEcCtD
Cysteamine—Abdominal pain—Capecitabine—colon cancer	0.000661	0.00245	CcSEcCtD
Cysteamine—Body temperature increased—Capecitabine—colon cancer	0.000661	0.00245	CcSEcCtD
Cysteamine—Convulsion—Methotrexate—colon cancer	0.000661	0.00245	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000645	0.00239	CcSEcCtD
Cysteamine—Discomfort—Methotrexate—colon cancer	0.000642	0.00237	CcSEcCtD
Cysteamine—Confusional state—Methotrexate—colon cancer	0.000628	0.00232	CcSEcCtD
Cysteamine—Anaphylactic shock—Methotrexate—colon cancer	0.000623	0.0023	CcSEcCtD
Cysteamine—Hypersensitivity—Capecitabine—colon cancer	0.000616	0.00228	CcSEcCtD
Cysteamine—Nervous system disorder—Methotrexate—colon cancer	0.000611	0.00226	CcSEcCtD
Cysteamine—Skin disorder—Methotrexate—colon cancer	0.000605	0.00224	CcSEcCtD
Cysteamine—Asthenia—Capecitabine—colon cancer	0.0006	0.00222	CcSEcCtD
Cysteamine—Anorexia—Methotrexate—colon cancer	0.000593	0.0022	CcSEcCtD
Cysteamine—Diarrhoea—Capecitabine—colon cancer	0.000572	0.00212	CcSEcCtD
Cysteamine—Somnolence—Methotrexate—colon cancer	0.000553	0.00205	CcSEcCtD
Cysteamine—Dizziness—Capecitabine—colon cancer	0.000553	0.00205	CcSEcCtD
Cysteamine—Dyspepsia—Methotrexate—colon cancer	0.000548	0.00203	CcSEcCtD
Cysteamine—Decreased appetite—Methotrexate—colon cancer	0.000541	0.002	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000537	0.00199	CcSEcCtD
Cysteamine—Fatigue—Methotrexate—colon cancer	0.000537	0.00199	CcSEcCtD
Cysteamine—Vomiting—Capecitabine—colon cancer	0.000532	0.00197	CcSEcCtD
Cysteamine—Rash—Capecitabine—colon cancer	0.000527	0.00195	CcSEcCtD
Cysteamine—Dermatitis—Capecitabine—colon cancer	0.000527	0.00195	CcSEcCtD
Cysteamine—Headache—Capecitabine—colon cancer	0.000524	0.00194	CcSEcCtD
Cysteamine—Feeling abnormal—Methotrexate—colon cancer	0.000513	0.0019	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methotrexate—colon cancer	0.000509	0.00188	CcSEcCtD
Cysteamine—Nausea—Capecitabine—colon cancer	0.000497	0.00184	CcSEcCtD
Cysteamine—Urticaria—Methotrexate—colon cancer	0.000495	0.00183	CcSEcCtD
Cysteamine—Abdominal pain—Methotrexate—colon cancer	0.000492	0.00182	CcSEcCtD
Cysteamine—Body temperature increased—Methotrexate—colon cancer	0.000492	0.00182	CcSEcCtD
Cysteamine—Hypersensitivity—Methotrexate—colon cancer	0.000459	0.0017	CcSEcCtD
Cysteamine—Asthenia—Methotrexate—colon cancer	0.000447	0.00165	CcSEcCtD
Cysteamine—Diarrhoea—Methotrexate—colon cancer	0.000426	0.00158	CcSEcCtD
Cysteamine—Dizziness—Methotrexate—colon cancer	0.000412	0.00152	CcSEcCtD
Cysteamine—Vomiting—Methotrexate—colon cancer	0.000396	0.00146	CcSEcCtD
Cysteamine—Rash—Methotrexate—colon cancer	0.000393	0.00145	CcSEcCtD
Cysteamine—Dermatitis—Methotrexate—colon cancer	0.000392	0.00145	CcSEcCtD
Cysteamine—Headache—Methotrexate—colon cancer	0.00039	0.00144	CcSEcCtD
Cysteamine—Nausea—Methotrexate—colon cancer	0.00037	0.00137	CcSEcCtD
